Commissioning cranial single-isocenter multi-target radiosurgery for the Versa HD.

J Appl Clin Med Phys

Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, 48073, USA.

Published: April 2021

Purpose: Brainlab's Elements Multiple Brain Mets SRS (MBMS) is a dedicated treatment planning system for single-isocenter multi-target (SIMT) cranial stereotactic radiosurgery (SRS) treatments. The purpose of this study is to present the commissioning experience of MBMS on an Elekta Versa HD.

Methods: MBMS was commissioned for 6 X, 6 FFF, and 10 FFF. Beam data collected included: output factors, percent depth doses (PDDs), diagonal profiles, collimator transmission, and penumbra. Beam data were processed by Brainlab and resulting parameters were entered into the planning system to generate the beam model. Beam model accuracy was verified for simple fields. MBMS plans were created on previously treated cranial SRS patient data sets. Plans were evaluated using Paddick inverse conformity (ICI), gradient indices (GI), and cumulative volume of brain receiving 12 Gy. Dosimetric accuracy of the MBMS plans was verified using microDiamond, Gafchromic film, and SRS Mapcheck measurements of absolute dose and dose profiles for individual targets. Finally, an end-to-end (E2E) test was performed with a MR-CT compatible phantom to validate the accuracy of the simulation-to-delivery process.

Results: For square fields, calculated scatter factors were within 1.0% of measured, PDDs were within 0.5% past dmax, and diagonal profiles were within 0.5% for clinically relevant off-axis distances (<10 cm). MBMS produced plans with ICIs < 1.5 and GIs < 5.0 for targets > 10 mm. Average point doses of the MBMS plans, measured by microDiamond, were within 0.31% of calculated (max 2.84%). Average per-field planar pass rates were 98.0% (95.5% minimum) using a 2%/1 mm/10% threshold relative gamma analysis. E2E point dose measurements were within 1.5% of calculated and Gafchromic film pass rates were 99.6% using a 5%/1 mm/10% threshold gamma analysis.

Conclusion: The experience presented can be used to aid the commissioning of the Versa HD in the Brainlab MBMS treatment planning system, to produce safe and accurate SIMT cranial SRS treatments.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035552PMC
http://dx.doi.org/10.1002/acm2.13223DOI Listing

Publication Analysis

Top Keywords

single-isocenter multi-target
8
planning system
8
beam data
8
diagonal profiles
8
beam model
8
mbms plans
8
mbms
5
commissioning cranial
4
cranial single-isocenter
4
multi-target radiosurgery
4

Similar Publications

Article Synopsis
  • Researchers developed a new 3D-printed phantom called OneIso to improve quality-assurance procedures for brain radiosurgery, especially in multi-target treatments.
  • The phantom allows for multiple testing methods, including Winston-Lutz tests and dose measurements, without needing to relocate the phantom itself, enhancing precision and accuracy.
  • Validation across eight institutions showed that dose verification results using OneIso were consistently within 3% agreement, demonstrating the effectiveness of this integrated QA approach.
View Article and Find Full Text PDF
Article Synopsis
  • * A study evaluated the myQA SRS device, a high-resolution CMOS 2D detector, for its performance in PSQA by characterizing its dosimetric properties and conducting gamma index analyses on nine simulated and clinical plans.
  • * Results indicated that the myQA SRS showed excellent dosimetric agreement with dosimetry films, achieving average gamma index pass rates of 99.9% and 99.2%, demonstrating its reliability and potential as a modern alternative to traditional film dosim
View Article and Find Full Text PDF
Article Synopsis
  • Current treatments for oligometastatic non-small cell lung cancer (NSCLC) mainly involve systemic chemotherapy and immune checkpoint inhibitors, but there's a need for better methods due to common recurrences.* -
  • The first case using the Ethos OART platform for delivering targeted radiotherapy was presented, involving a 67-year-old man with stage IV NSCLC and multiple metastatic sites.* -
  • The treatment utilized advanced planning techniques and adaptive strategies, resulting in over 80% tumor shrinkage and highlighting the potential benefits of this approach, though further research is necessary to establish its safety and efficacy.*
View Article and Find Full Text PDF

Purpose: SRS MapCHECK (SMC) is a commercially available patient-specific quality assurance (PSQA) tool for stereotactic radiosurgery (SRS) applications. This study investigates the effects of degree of modulation, location off-axis, and low dose threshold (LDT) selection on gamma pass rates (GPRs) between SMC and treatment planning system, Analytical Anisotropic Algorithm (AAA), or Vancouver Island Monte Carlo (VMC++ algorithm) system calculated dose distributions.

Methods: Volumetric-modulated arc therapy (VMAT) plans with modulation factors (MFs) ranging from 2.

View Article and Find Full Text PDF

Background: Stereotactic radiosurgery (SRS) is a widely employed strategy for intracranial metastases, utilizing linear accelerators and volumetric modulated arc therapy (VMAT). Ensuring precise linear accelerator performance is crucial, given the small planning target volume (PTV) margins. Rapid dose falloff is vital to minimize brain radiation necrosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!